Three knee shots go Head-to-Head for lasting arthritis relief
NCT ID NCT05492851
First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time
Summary
Researchers at Ohio State University are running a double-blind, randomized trial to compare three single-dose injections for knee osteoarthritis: Zilretta, Synvisc-One, and Monovisc. The study enrolls adults aged 25 to 85 with painful knee osteoarthritis that continues despite physical therapy and pain medication. Participants receive one of the three injections, and researchers track changes in knee pain and symptoms using a standard questionnaire. The goal is to see whether one injection offers better relief than the others.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Three injectable knee osteoarthritis treatments: Zilretta, Synvisc-One, and Monovisc
- What this could lead to
- If one injection works better, doctors could have clearer guidance on which single shot to offer patients whose knee osteoarthritis pain persists after exercise and pain relievers.
- What could go wrong
- The trial plans to enroll only 6 people, so any differences between the three injections may be too small to trust. Results might not apply to everyone with knee osteoarthritis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
6 people
The number who actually took part.
- Started
-
Aug 2022
- Finished
-
Jan 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 25-85 years * BMI \< 40 * Diagnosis of unilateral knee OA * Radiographic evidence of OA of the target knee (Kellgren-Lawrence grades 2-4) * Continued OA pain in the target knee despite at least 6 weeks of: physical therapy and at least one of the following: activity modification (such as reducing impact on the knee), weight loss, and a 2 week trial of NSAID / acetaminophen. * Knee Osteoarthritis Outcomes Score (KOOS)-Pain subscale 20-65 * Working knowledge of English language (to be able to complete all outcome scores) * Ability to attend all follow-up appointments Exclusion Criteria: * 3+ effusion of the target knee (stroke test grading system) * Prior injection therapy: * Steroid injection in target knee in the last 3 months * Viscosupplementation in target knee in the last 6 months * PRP in the target knee in the last 6 months * Cellular treatments in index knee (bone marrow, amniotic suspensions etc) 1 year * Participation in any experimental device or drug study within 1 year before screening visit * Oral or IM steroids in the last 3 months (Inhaled steroids used in the treatment of asthma/allergies are permitted) * Medical condition that may impact outcomes of procedure including: * Systemic inflammatory disorders that impact the joints like rheumatoid arthritis, lupus, etc * Undergoing current cancer treatment (other than non-melanoma skin malignancies) * Taking immunosuppressants * Previous cartilage repair procedure on the injured cartilage surface (ie, OATS, ACI, MFX) in the last 5 years * Previous surgery at the target knee within the past 1 year * Any degree of cognitive impairment * Symptomatic OA of any other joint in the lower limbs * Pregnancy, lactating, or intent to become pregnant during treatment period (Female participants will be asked if they are pregnant, lactating, or intend to become pregnant during treatment) * Gout, Pseudogout (including radiographic evidence of chondrocalcinosis) * History of infection or current infection at the affected joint * Smoking (Former smokers\< 1 year from quit date)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Osteoarthritis, knee are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jameson Crane Sports Medicine Institute
Columbus, Ohio, 43202, United States
-
Ohio State Outpatient Lewis Center
Lewis Center, Ohio, 43035, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which anesthesia gets joint replacement patients moving sooner?
- Can a special MRI match CT for spotting knee bone damage?
- Can a common bleeding drug make knee realignment surgery safer?
- One shot, new knee? gene therapy trial aims to quiet arthritis pain
- Gel shot vs standard injection: which quiets arthritic knees?
- Can tracking daily life with knee osteoarthritis improve care?